← Back to headlines
Trump's FDA Nominee Faces Scrutiny Over Abortion Drug Oversight
A pro-life advocacy leader predicts that Trump's FDA nominee, Heidi Overton, will intensify regulatory review of mifepristone following her confirmation.
25 Aug, 17:38 — 25 Aug, 17:38
Related Stories
Austria Faces Outcry Over Business Park Planned on Former Nazi Camp Site
9m ago
CIA Director Ratcliffe’s High-Security Moscow Visit Sparks Diplomatic Speculation
17m ago
Trump Administration Pursues Major U.S. Stake in Venezuelan Oil Sector
30m ago
Norway Mourns and Transitions Power Following King Harald V’s Death
40m ago